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a b s t r a c t
The study of biomolecular interactions is crucial to get more insight into the biological system. The inter-
actions of protein-protein, protein-nucleic acids, protein-sugars, nucleic acid-nucleic acids and protein-
small molecules are supporting therapeutics and technological developments. Recently, the development
in a large number of analytical techniques for characterizing biomolecular interactions reflect the promis-
ing research investments in this field.
In this review, microscale thermophoresis technology (MST) is presented as an analytical technique for
characterizing biomolecular interactions. Recent years have seen much progress and several applications
established. MST is a powerful technique in quantitation of binding events based on the movement of
molecules in microscopic temperature gradient. Simplicity, free solutions analysis, low sample volume,
short analysis time, and immobilization free are the MST advantages over other competitive techniques.
A wide range of studies in biomolecular interactions have been successfully carried out using MST, which
tend to the versatility of the technique to use in screening binding events in order to save time, cost and
obtained high data quality.
 2018 Elsevier Inc. All rights reserved.
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1. Introduction
Biomolecular interactions are fundamental nowadays to pro-
vide a good understanding towards most of bioprocesses in living
systems. Thus, characterization of protein-protein, protein-
nucleic acids, protein-sugars, nucleic acid-nucleic acids and
protein-small molecules is important and crucial in the life
sciences and provides deep insight into the biological outcomes
that may help in disease diagnosis, prognosis and therapeutics as
well improve the quality of the life [1–3]. Various analytical tech-
niques that have been used to characterize biomolecular interac-
tions. Some of these techniques include affinity-based separation
techniques, which represent the major domain of affinity chro-
matography, [4–6] and affinity capillary electrophoresis [7–9] as
well as equilibrium dialysis, which is still interesting and widely
used especially in drug-protein interaction studies [10–12]. On
the other hand, biochemical and biophysical techniques are attrac-
tive and developed dramatically to be the first choice in studying
biomolecular interactions. Examples include spectroscopic tech-
niques [13–18], surface plasma resonance (SPR) [19–21], isother-
mal titration calorimetry (ITC) [22–24] and microscale
thermophoresis (MST) [25–27]. This review will discuss ther-
mophoresis in the characterization of biomolecular interactions.
The technique is gaining popularity in recent years as a powerful
technique in the characterization of biomolecular interaction. In
this paper, theory, fundamentals, technical and practical consider-
ations are discussed in detail. Different applications that use
microscale thermophoresis as a selected analytical technique in
biomolecular interaction studies are followed by a discussion to
such literature examples.
2. Thermophoresis
2.1. Overview
Thermophoresis, also known as thermal diffusion or Soret
effect, is a physical phenomenon corresponding to the direct
motion of molecules induced by a temperature gradient, typically
from the hot zone to cold zone. Thermophoresis was discovered
by Ludwig in the 19th century and has since been widely applied
in inorganic chemistry and polymer separations [28]. Dieter Braun
and Albert Libchaber reported for the first time the thermophoretic
diffusion of DNA and quantified thermal diffusion constant using
fluorescence dyes and laser heating; thus, a new approach has been
introduced to study thermophoresis for biomolecules [29]. Robert
Piazza and co-workers presented a case study of protein solutions
and provided theoretical explanations to thermal diffusion of lyso-
zyme protein [30,31]. Philip Reineck and co-workers investigated
thermophoresis of single-strand DNA in microscopic scale rectan-
gular capillary with a 50-mm cross-section and pointed out that
use of capillary is reliable as a microfluid environment to investi-
gate optically thermophoresis in solution [32]. Thereafter, ther-
mophoresis in microscale measurements was introduced in the
realm of binding studies. Furthermore, MST has been developed
in order to address obstacles such as labeling specificity and pro-
tein stability. MST label-Free system was introduced by Susanne
A. I. Seidel and coworkers to study protein-ligand interaction
depending on intrinsic tryptophan residues in protein [33].
2.2. Microscale thermophoresis
Microscale thermophoresis (MST) is defined as a method of
monitoring the movement of fluorescent molecules through a
microscopic temperature gradient. This technique depends on
thermophoresis principle of detecting optical fluorescence proper-
ties to analyses the binding affinity of different molecules. MST dis-
plays molecular thermal diffusion in few microliters of sample
solution [34]. Thus, MST has several advantages over other
fluorescence-based analytical techniques, such as simplicity, low
sample volume, label-free options, and detecting changes in hydra-
tion shell and charges of biomolecules as well as size changes
through the binding events [35]. Additionally, MST overcomes
some technical obstacles for non-fluorescent techniques; MST
offers the immobilization-free system in comparison to SPR, which
needs surface artifact. ITC consumed high volumes of sample in
comparison to MST which consumed ml-volume of sample regard-
less of time, system complications and low throughput which gives
significant preference for MST. Therefore, MST monitors molecular
thermophoresis, which relies on numerous molecular properties
and thus provides versatility in applicability and system flexibility
[26,34–36].
2.2.1. Theoretical background of MST
Through infrared (IR) laser beam with emission wavelength
1480 nm (Fig. 1A), the local heating of aqueous solution in diame-
ter of 50 mm and temperature difference DT  2–6 K will gener-
ate molecular flow (j) which is directly proportional to
temperature gradient with proportionality constant DT. In steady
state, thermophoretic flow opposed by mass diffusion and both
effects being balanced, which describe as:
j ¼ cDT grad T
j ¼ D grad c
j: molecular flow; c: molecular concentration; DT: Thermal diffusion
coefficient; T: temperature; D: diffusion coefficient. The D/DT ratio
is defined as a Soret coefficient (ST):
ST ¼ DDT
ST describes the concentration ratio under steady-state conditions
and given by:
ST :
Chot
Ccold
¼ exp STDTð Þ
where Chot is the concentration of molecules at the hot zone and
Ccold is the concentration of molecules at the cold zone. ST is Soret
coefficient, which is affected by the factors described in the follow-
ing equation:
ST ¼ AkT Dshyd Tð Þ þ
br2eff
4ee0T
 kDH
 !
where A is the surface area of the molecules, k is Boltzmann con-
stant, T is temperature of system, reff is the effective charge, Dshyd
is the hydration shell effect, kDH is the Debye-Hückel screening
length, e is the dielectric constant, and b is temperature derivative
of e. Therefore, since the conformational changes are dealing with
the biomolecules such as effective charges, hydration entropy or
molecular surface area provide information for binding affinity.
In principle, MST signal that obtained involves numerous subse-
quent processes. Initially, MST records fluorescence in the focal IR-
laser zone at ambient temperature without laser heating, which is
called initial state (Fig. 1B-I). Next, IR-laser turns on heating speci-
fic focal zones in the sample solution and leads to changes in fluo-
rescence intensity known as T-jump (Fig. 1B-II). After T-jump,
thermophoretic movements of the molecules start and fluores-
cence intensity will decrease till it reaches the steady state,
depending on molecular depletion out of the heated zone accord-
ing to the typical thermophoresis, described as the movement of
molecules from hot to cold zone (Fig. 1B-III). Thereafter, IR-laser
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switches off to induce mass diffusion of molecules, depending on
concentration gradient, called back-diffusion state (Fig. 1B-IV).
The total time for each MST signal takes 35 s. Herein, binding
quantifications is taking place by analyzing the change in fluores-
cence intensity, which is estimated as relative fluorescence (nor-
malized fluorescence), according to the following equation:
Fnorm ¼ Fhot=Fcold
where, Fnorm: normalized fluorescence; Fhot: fluorescence in heated
zone; Fcold: fluorescence at initial state or in cooling state. The differ-
ences in Fnorm of the bound and unbound state (depend on the con-
centration of titrated partner) allow to estimate fraction bound (FB)
according to the following equation:
Fnorm ¼ ð1 FBÞFnormðunboundÞ þ ðFBÞFnormðboundÞ
Thus, Fnorm is used to quantify the concentration of fluorescent
molecules, which are temperature dependent and governed by
the flowing equation:
Fnorm ¼ Fhot=Fcold ¼ 1þ dFdT  ST
 
DT ¼ Chot
Ccold
þ dF
dT
DT
2.2.2. MST instruments
MST instrument consists of optic, which allows the visible light
to trigger fluorescence excitation and emission in specific mm-zone
for the sample. Infrared IR-laser with a wavelength 1480 nm is
reflected using a dichroic mirror to couple into the same path of
visible light (Fig. 1A). This well-designed setup with IR radiations
focused on the spot that the fluorescence is measured to exhibit
precise observation for sample thermophoresis. To our knowledge,
there is one brand for manufacturing of MST instruments. Whereas
Nano-temper technologies GmbH (Munich, Germany) offered dif-
ferent types of MST instruments they all possess the same principle
but differentiates in detection capabilities. The Monolith NT.115
MST instrument possesses different types of LED-filter: blue (exci-
tation 460–480 nm, emission 515–530 nm), green (excitation 515–
525 nm, emission 560–585 nm), red (excitation 605–645 nm,
emission 680–685). However, there are different models of Mono-
lith NT.115 MST instruments depending on the range of detection.
These types of instrument are used to quantify biomolecular inter-
actions via detection of fluorescent dyes or fluorescent fusion pro-
tein. The Monolith NT.115 Label-Free MST instrument has an
excitation wavelength of 280 nm and an emission wavelength of
360 nm as well as the detection of visible light with a wavelength
range of 480–720 nm, which allow detecting of intrinsic molecular
fluorescence in this range without the need to label procedures. In
this regard, proteins with high tryptophan contents are more suit-
able for investigation using Monolith NT.115 Label-Free MST
instrument. On the other hand, the Monolith NT.115Pico MST
instrument is designed for high-affinity interactions with a sub-
Nanomolar scale that enable to detect any red emitted fluo-
rophores in low-picomolar concentrations. Furthermore, to mini-
mize human errors and provide better control of analysis, the
automation of MST system has been developed as Monolith NT.
automated MST instrument. The MST instrument has a capacity
of up to 16 samples that can be loaded in each run and the sample
Fig. 1. A) Schematic setup of MST instrument. B) Thermophoresis signal. C) Thermophoretic signals for bound/unbound molecules (left), Binding curve (right). (Adapted with
permission from Ref. [28]).
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volume of 4 ml. Capillaries are made of pure glass for standard use;
coated capillaries can be used for sticky samples to avoid sample
adsorption to the capillary wall.
2.2.3. MST experimental setup and optimizations
The good experimental design is the key to work. MST like all
analytical techniques, needs to perform experimental setup and
optimization of experimental conditions as shown in the general
scheme which explains series of preparation steps for MST exper-
iment (Fig. 2). Hence, concentration range, labeling procedures,
solvent, proper select of the capillary, capillary filling, LED set
and Temperature set should be conducted carefully to achieve
good MST measurements.
2.2.3.1. Labeling procedures. MST detection as mentioned before
depends on measuring the fluorescence intensity of labeled part-
ner or intrinsic fluorophores in label-Free MST system. Therefore,
labeling procedure is critical for MST experiments to provide
highly sensitive measurements of labeled molecules. Typically,
the labeling process is conducted through linking of the specific
functional group in dye to crosslinker reactive group. For example,
using N-hydroxysuccinimide esters known as ‘‘NHS-ester” as link-
ers to react with a primary amine in targeted protein as well Mal-
eimide dyes are used to bind with sulfhydryl groups present in
reduced cysteine. However, these types of labeling need
washing-up steps before the MST measurements to remove unre-
acted dye molecules. Alternatively, recombinant proteins which
contain fluorescence protein such as green fluorescence protein
can be used to fused with specific peptide sequence. Generally,
in all fluorescence ligand-based binding assays including MST,
the labeling process is a significant pitfall and may alter the ligand
properties, regardless of time consumed, multi-cleaning steps and
difficult optimization for some biomolecules. In addition, MST in
principle is not affected by fluorescent position or fluorescence
levels when compared with other competitive techniques, whereas
thermophoresis responds to minor changes inside the system such
as charges, hydration shells as well as molecular size [26,33,37].
2.2.3.2. Solvent and concentration range considerations. It is known
that MST technique is compatible with all buffering systems, with-
out restrictions. However, the buffer may play a critical role in pro-
tein aggregations. Yexuan Mao et al. [27] reported the effect of
solvents on the aggregation of human islet amyloid polypeptides
[11–20]. They found different behaviors of the peptides aggrega-
tion under different buffering systems. On the other hand, MST
instruments have different capabilities for fluorescence detection
in wide concentration ranges; however, in low picomolar concen-
trations, the quantification of molecular interactions is difficult
although it was detected. Therefore, use of Monolith NT.115pico is
necessary for accurate quantitative measurements [38].
2.2.3.3. Capillary. In MST technique, the samples were loaded in
capillaries with well-defined capacity, outer and inner diameters,
because all of these factors affect MST measurements. In each
experiment, 16 samples can be loaded into capillaries tray. The
sample loading occurs through capillary forces. Therefore, capillary
scanning test is critical prior to each measurement to optimize the
MST experiment and avoid any handling errors, sample adsorption
or fluorescence quenching/enhancement by ligand. To avoid sam-
ple adsorption, different types of coated capillaries with hydropho-
bic/hydrophilic polymers can be used as alternatives to standard
glass capillaries or add detergent to the buffer system.
Fig. 2. General scheme for sample preparation steps.
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2.2.3.4. LED and temperature set. Manipulation of excitation light
power and temperature is enabled in an MST instrument, to obtain
a proper fluorescence intensity and thermophoresis. The excitation
light power called ‘‘LED power” could be set with different power
intensity to obtain fluorescence intensity between 200 and 1500
counts, which is suitable signal detections. Laser intensity called
‘‘MST power” could be manipulated to induce optimal ther-
mophoresis and raise local temperature between 2 C and 6 C.
2.2.4. MST data analysis
Currently, MST data fit in two different binding models which
solved by available Nanotemper software. First model, is Kd model
which is driven from law of mass action:
Aþ B$ AB
A: binding partner A; B: binding partner B; AB: complex
The equilibrium dissociation constant Kd as:
Kd ¼
½Afree  ½Bfree
½AB
Whereas, free concentrations of each partner are not known. Total
concentrations are used according to the following formula:
A½  ¼ A½ free þ AB½  and B½  ¼ ½Bfree þ ½AB
½Afree: free concentration of partner A; ½Bfree: free concentration of
partner B; ½AB: bound complex concentration.
Hence, Kd is calculated as follow:
Kd ¼ ð A½   AB½ Þð B½   AB½ Þ½AB
Then, fraction bound FB is calculated as a total concentration of A
and B and correlated with Kd parameter as follows:
FB ¼
A½  þ B½  þ Kd 
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
ð A½  þ B½  þ KdÞ2  4½AB
q
2½B
Where, FB represents linearity with normalized fluorescence
formMSTmeasurements. The binding curve is obtained by plotting
normalized fluorescence Fnorm on y-axis against total concentration
of titrated partner and dissociation constant Kd can be determined
easily. The aforementioned model is fitted with obtained data if the
binding ratio is 1:1 stoichiometry. In more complicated binding
ration, Hill equation is the second model to estimate EC50 value,
which is defined as a half maximum concentration of titrated bind-
ing partner. EC50 is not a physical constant and provide informa-
tion about the cooperativity of binding events in multivalent
interactions.EC50 from Hill equation can be represented as follow:
½A þ n½B $ ½ABn
Where, n is Hill coefficient and FB can have calculated as follow:
FB ¼ 1
1þ ðEC50=BÞn
B: provided concentration of titrated partner.
3. Applications
3.1. MST of protein interactions
Protein interactions exhibit important roles in many cellular
processes, such as cell regulation and transportation, and to induce
of many cellular functions. Therefore, in vitro approaches to mea-
suring biomolecular interactions have a great effect to technologi-
cal applications such as antigen–antibodies affinity, protein
characterization, stabilities and drug discoveries. Herein, we pro-
vide an overview using of MST of protein interactions for different
applications.
3.1.1. Protein-protein interactions
The applications of MST in protein-protein interactions vary
and are growing, For example, Wienken et al. [28] introduced
MST for the first time in the characterization of immunoaffinity
for targeted proteins. The first approach described interaction
between human interferon-gamma (hIFN-c) and IFN-c antibodies
whereas; the second approach determined affinity between green
fluorescent protein (GFP) and small antibody fragment, known as
GFP-binding protein (GBP). The dissociation constants were
Fig. 3. A) Activation pathway of b1-adrenergic receptor (left), synthetic COR1 peptide (right upper), labeled COR1 peptide (right bottom). B) binding curve of monoclonal
antibodies to COR1 peptide in PBS buffer and 50% human serum. C) binding curve of polyclonal antibodies to COR1 peptide in PBS buffer and 50% human serum. (Adapted
with permission from Ref. [39]).
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successfully determined to be Kd = 10 nM for (hIFN-c) -(IFN-c-
antibody) and Kd = 2.3 nM for GFP-GBP interactions. MST data of
GFP-GBP experiment were compared with data that obtained from
quartz crystal microbalance sensor (QCM) and found good agree-
ment between two estimated physical dissociation constants. In
this regard, MST is liberating strong physical effect which would
be able to estimate the binding events of biomolecules in their
native environment and invest this feature in quantification of
disease-related biomarker and drug discovery as described by Lip-
pok et al. [39]. Whereas, MST was used to quantify the interaction
between autoimmune antibodies (b1-adrenergic receptor autoan-
tibodies) and an artificial peptide antigen (COR1) which is designed
to act as a candidate peptide drug in the treatment of dilated car-
diomyopathy (Fig. 3A). The affinity of labeled COR1 to monoclonal
and polyclonal antibodies was quantified under two different con-
ditions either in buffer or 50% human serum. The binding events
were determined as the dissociation constant (KD). Moreover,
binding specificity was confirmed by control experiment using
non-specific antibodies (Fig. 3B and C). On the other hand, MST
was exploited in different applications of protein-protein
interactions to prove the role of some proteins in cancer initiation
or prognosis as well as disease diagnosis. For example, Arbel at al.
[40] used MST to investigate the interactions between Bcl-xL pro-
teins and VDAC1 protein (voltage-dependent anion channel-
isoform1). This approach was carried out to prove the interaction
between Bcl-xL and VDAC1; however, Bcl-xL are overexpressed
in cancer and drug resistance might be attributed to their anti-
apoptotic activity. MST successfully quantified the binding events
of Bcl-xL-VDAC1 (Kd = 0.67 mM). Moreover, VDAC1-based peptides
were synthesized to act as a targeted drug in suppression anti-
apoptotic activity of Bcl-xL protein. Similarly, Liu et al. [41] used
MST to investigate direct interaction of fibrous sheath interacting
protein 1 (FSIP1) to human epidermal growth factor receptor 2
(HER2). Where, FSIP1 is a known biomarker correlate to HER2 in
growth and metastasis of breast cancer. MST results revealed that
binding affinity between intracellular domain (B2) of HER2 and all
recombinant FSIP1 fragments, especially (A2) FSIP1 with (B2) HER2
and the estimated Kd = 0.25 mM. Other binding events indicated
weak affinity between two molecules. Recently, Löf et al. [42]
investigated the interactions between plasma glycoprotein (VWF-
CK domain), which is considered an important protein in platelet
aggregations during vascular injury, and protein disulfide
Table 1
MST of protein-protein interactions.
Analytical application Interacting molecules Binding parameters Comparative technique Ref.
Antigen-antibody
interactions
Human Interferon-gamma
(hIFN-c) and hIFN-c antibody
The binding events determined as dissociation
constant Kd = 10 ± 2 nM
[28]
Antigen-antibody
interactions (small
fragment Abs for GFP
Green fluorescent protein (GFP)
with small fragment antibody
(GBP)
The binding events determined as dissociation
constant Kd = 2.3 ± 2.1 nM
QCM Kd = 0.63 nM [28]
Characterization of
antiapoptotic activity
for Bcl-xL protein
Voltage-dependent anion
channel isoform 1 (VDAC1) and
Bcl-xL protein
The binding events determined as dissociation
constant Kd = 0.67 mM
[40]
Breast cancer biomarkers Fibrous sheath interacting
protein 1 (FSIP1) and human
epidermal growth factor
receptor 2 (HER2)
3 FSIP1 isoforms bind to B2 HER2 domain
where, A1-B2 Kd = 0.80 ± 0.19 mM A2-B2 Kd =
0.25 ± 0.06 mM A3-B2 Kd = 1.08 ± 0.25 mM
[41]
Functional and structural
characterization of
glycoprotein.
Von Willebrand factor (VWF)
glycoprotein and protein
disulfide isomerase -A1 isoform
(PDIA1)
The binding events determined as dissociation
constant Kd = 236 ± 66 nM
FCS Kd = 282 ± 123 nM [42]
Characterization of
inhibitory functions of
synthetic Ca2+ channel
peptides
Collapsing response mediator
protein 2 (CRMP2) and L1 or Ct-
dis synthetic peptides
The binding events determined as dissociation
constant CRMP2-L1 Kd = 3 mM CRMP2-CT-dis
Kd = 0.64 mM
[43]
Discovery of therapeutic
peptide
COR1 peptide and autoimmune
antibody
The binding events determined as dissociation
constant Kd = 75 nM
[39]
Protein dimerization Two monomers of Growth
factor receptor-bound protein 2
(Grb2)
The binding events determined as dissociation
constant Kd = 0.66 ± 0.2 mM
[44]
Characterization of cell
surface receptor
binding to
hemagglutinin protein
of H5N1 virus
Human or avian receptors and
recombinant hemagglutinins
(HAs)
Transmissible HA-human receptor kd = 12 mM
Wild type HA-human receptor Kd = 17 mM
Transmissible HA-avian receptor Kd = 32 mM
[45]
Protein phosphorylation Renal water cannel aquaporin-
2 (AQP2) and lysosomal
trafficking regulator-
interacting protein -5 (LIP5)
The dissociation constant Kd was determined
for different AQP2 mutants in range of 278 nM
to 1 mM in comparison to wild type AQP2-LIP5
Kd = 191 nM
[46]
Quantitation of proteins
aggregates
a- synuclein oligomer and
monomer species (Syn2) and
Nano-antibody (Nb Syn2)
The binding events determined as dissociation
constant Oligomer-Nb syn2 Kd = 234 ± 49 nM
Monomer-Nb syn2 Kd = 124 ± 35 nM
[47]
Characterization of protein
inhibition effect in
plasma sample
Neutrophil elastase (NE) and a-
antitrypsin (AAT)
The Kd was determined in two pool plasma
samples FEV1  80% Kd = 500 ± 100 nM FEV1
 50% Kd = 1300 ± 250 nM
[48]
Characterization of lipid
metabolic regulations
Aspergillus oryzae acyl-coA
binding protein (AoACBP) and
palmitoyl-CoA or myristoyl-
CoA
The binding events determined as dissociation
constant AoACBP-palmitoyl-CoA Kd = 80 nM
AoACBP-myristoyl-CoA kd = 510 nM
[49]
Protein scaffold b-trypsin and miniprotein
chains
MST binding events determined as
dissociation constant b-trypsin-BHV Kd = 105
± 29 nM b-trypsin-BVB Kd = 104±18 nM b-
trypsin-HBH Kd = 106 ± 25 nM
SPRi The binding events determined as
dissociation constant b-trypsin-BHV Kd = 78 ±
12 nM b-trypsin-BVB Kd = 44 ± 8 nM b-
trypsin-HBH Kd = 86 ± 18 nM
[50]
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isomerase isoform A1 (PDIA1) to prove specific and direct interac-
tion and characterize VWF dimerization. MST and fluorescence
correlation spectroscopy (FCS) techniques were used to measure
binding constant where the dissociation constants that determined
by MST and F Kd = 236 nM and Kd = 282 nM, respectively. Different
applications [43–50] of MST technique in the characterization of
protein-protein interactions are summarized in Table 1.
3.1.2. Protein-small molecule interaction
The binding of small molecule ligands to large protein mole-
cules is crucial in several biological processes. Indeed, MST was
merged largely in this field as a novel technique for characteriza-
tion of protein-small molecules interaction although, quantifica-
tions of these interactions are difficult due to lack of significant
changes in bulk size or charges of the complex. Thus, the sensitivity
of detection is critically affected; however, MST is still capable of
detecting the binding events as change in molecular solvation
entropy [26,35]. There are several applications for using of MST
in measuring small molecules affinity to proteins for therapeutic
and technological developments. Drug discovery is the mainstream
of different experimental approaches in protein-small molecule
interactions, and a large number of studies are consistent with this
general aim [51–57]. For instance, Patniak et al. [58] investigated
the affinity of candidate small lead compounds to glucocerebrosi-
dase enzymes (GCase). MST approaches were carried out after high
throughput screening for a huge number of lead compounds to
identify series of compounds that activate GCase, which is consid-
ered a good target drug for treatment of Gaucher disease. More-
over, Rogez-Florent et al. [57] investigated the enantioselective
affinity of new sulfonamide derivatives to human carbonic anhy-
drase enzymes. In this substantial approach, MST and SPR were
used for the interaction study. On the other hand, the small mole-
cules inhibitory effect was investigated extensively via MST [59–
64]. Where, Shang et al. [60] successfully investigated small mole-
cule as inhibitor G-protein-coupled Rho guanine nucleotide
exchange factors. MST was used to estimate the binding affinity
between small molecule (Y16) and LARG DH-PH protein and the
dissociation constant Kd of 76 nM to be a candidate as an anti-
cancer agent. Another example, Welsch et al. [63] recently, inves-
tigated multivalent small molecule as an inhibitor for Pan-RAS
proteins, which are strongly involved in numerous malignancies.
In protein production technology, MST is a robust technique for
testing the purified proteins and confirming their functionalities.
In this context, Wang et al. produced G protein-coupled receptors
using commercial E. coli cell-free kits with selected peptides as sur-
factant [65]. They succeeded to produce milligram quantities of
GPCRs; MST was used to confirm the ability of purified receptors
to bind with their ligands. Another approach was used by Wester-
maier et al. [66], who studied the effect of excipients on the initial
self-association of therapeutic antibody bevacizumab and breaking
protein aggregation. In silico screening of several targeted mole-
cules as aggregation breakers, adenosine monophosphate (AMP)
showed better aggregation breaking properties (Fig. 4A–C). MST
was used to investigate the interactions between AMP and beva-
cizumab using both MST systems (labeled and label-Free MST).
Furthermore, the dissociation constant for self-interaction
between two bevacizumab monomers was estimated (Fig. 4D
and E). In this approach, the labeling process exhibited a great
effect on binding events (Kd = 27.5 mM) in comparison to label-
Free MST system (Kd = 9.59 mM). Several applications [67–69] such
as protein characterizations and protein stability are summarized
elsewhere in Table 2.
3.2. MST of nucleic acids interactions
The characterization of nucleic acids (NAs) interactions is highly
significant in the life sciences. NAs are a good target in the study of
several biological interactions, such as drug discovery and develop-
ment, protein characterization and catalytic mechanisms. The
thermophoretic effect was studied for DNA/RNA stabilities in the
early stage [32,70]. For binding events, NAs are a good target in
the study of several biological interactions, such as drug discovery
Fig. 4. A) molecular docking of interaction between AMP and bevacizumab monomer. B) AMP chemical structure, dotted line represent suspected binding group to second
bevacizumab monomer with specific serine/lysine residues. C) molecular docking of dimer aggregation model in presence of AMP as aggregation breaker. D) binding curves of
AMP-Bevacizumab using label-Free MST system. E) binding curves of AMP-Bevacizumab with labeling of bevacizumab. (Adapted with permission from [66]).
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Table 2
MST of protein-small molecules interactions.
Analytical application Interacting molecules MST binding parameters Comparative techniques Ref.
Drug discovery of
new neutrophil
elastase inhibitors
Human neutrophil elastase (HNE)
and ursolic acid
Inhibitory constant was determined as Ki HNE-
ursolic acid Ki = 2.72 ± 0.66 mM
CE Ki = 2.81 ± 0.05 mM [51]
Characterization of
antiviral activity of
small molecules
Tobacco mosaic virus coat protein
(TMVCP) and small molecules
(chalcone derivatives) in addition
to ningnanmycin and ribavirin
TMVCP-7 h Kd = 9.51 mM TMVCP-7r Kd = 34.8
mM TMVCP-7j Kd = 162 mM TMVCP-
ningnanmycin Kd = 9.92 mM TMVCP-ribavirin
Kd = 473 mM
Fluorescence Spectoscopy Ka determined for
all binding events in range of 2.57  103 to
2.63  105 M
[52]
Tobacco mosaic virus coat protein
(TMVCP) and small molecules
(glucopyranoside derivatives)
The binding events determined as association
constant Ka as follow TMVCP-f6 Ka = 1.10 
105 M TMVCP-f18 Ka = 1.07  104 M TMVCP-
f31 Ka = 7.69  103 M
ITC TMVCP-f6 Ka = 1.79  105 M TMVCP-f18
Ka = 2.07  104 M TMVCP-f31 Ka = 1.76  103
M
[53]
Tobacco mosaic virus coat protein
(TMVCP) and small molecule
enantiomers (a-
aminophosphonate derivatives)
The binding events determined as association
constant Ka as follow: Q enantiomers with
TMVCP wild type (WT) TMVCP-Q-R Ka = 2.03
 105 M TMVCP-Q-s Ka = 8.26 x 103 M Q-R
enantiomer with Different mutants of TMVCP
(Q-R)-Q38G Ka = 2.93 x 104 M. (Q-R)-R90G Ka
= 3.66 x 103M (Q-R)-R91G Ka = 1.71 x 104 M
ITC Q enantiomers with TMVCP wild type (WT)
TMVCP-Q-R Ka = 1.81  105 M TMVCP-Q-s Ka
= 9.89  103 M Q-R enantiomer with Different
mutants of TMVCP (Q-R)-Q38G Ka = 9.10  104
M (Q-R)-R90G Ka = 8.76  103M (Q-R)-R91G
Ka = 2.08  104 M
[54]
South rice black-streacked dwarf
virus coat protein-P10 gene
(SRBSDVCP-P10) and small
molecules
The binding events determined as dissociation
constant P10-NNM Kd = 4.27 mM P10-F27 Kd =
7.81 mM
FT (Fluorescence titration) Binding events
determined as Ka P10-NNM Ka = 6.17  105 M
P10-F27 Ka = 5.75  105 M
[55]
Human heat-shock protein 90b
(Hsp90) and selected marine
alkaloids small molecules
The binding events determined as dissociation
constant Kd of four small molecules
compounds to Hsp90 in range of 18 – 79 mM in
comparison to control inhibitory compound
17-DMAG Kd = 0.27 mM
[56]
Enantioselective
inhibition for
human carbonic
anhydrase II
Human carbonic anhydrase II
(hACII) and different enantiomer of
synthetic sulfonamides
The binding events determined as dissociation
constant Kd of four enantiomer range of Kd 116
– 697 nM in comparison to reference
compound AZA that exhibited highest affinity
Kd = 41 nM
SPR The binding events determined as
dissociation constant Kd of four enantiomer
range of Kd 152 – 961 nM in comparison to
reference compound AZA that exhibited
highest affinity Kd = 38 nM
[57]
Drug discovery and
structure activity
relationship of
small molecule
chaperones
Glucocerebrosidase enzyme
(GCase) and small molecule
chaperone
The binding events determined as dissociation
constant GCase – compound 40 Kd = 8.91 mM
[58]
Protein aggregate
characterization
a- synuclein aggregates (a-syn) and
EGCG small molecule
The binding events determined as dissociation
constant a-syn fibril-EGCG Kd = 2.5 ± 0.4 mM a-
syn oligomer-ECGC Kd = 4.3 ± 0.8 mM
[47]
Shigella TGT enzyme
inhibition
tRNA-guanine transglycosylase of z.
mobilis (TGT) and four synthetic
small molecules
The binding events determined as dissociation
constant Compound 1 Kd = 1167 ± 152 nM
Compound 2 Kd = 1400 ± 500 nM Compound 3
Kd = 18.2 ± 7.0 mM Compound 4 Kd = 4 0.8 nM
[59]
Characterization of G-
protein coupling
inhibitors
LARG protein and Y16 small
molecule
The binding events determined as dissociation
constant LARG-Y16 Kd = 76 nM
[60]
Protein stability Adenylate kinase enzyme (AKE) and
(Ap5A) small molecule
The binding events determined as dissociation
constant AKE-Ap5A Kd = 33.4 ± 4 nM
[61]
Characterization of
Protein kinase
inhibitors
Human protein kinase 2-a subunit
(hCK2a) and four halogenated
benzotriazoles
The binding events determined as dissociation
constant hCK2a-5-BrBt Kd = 246 nM hCK2a-
5,6-Br2Bt Kd = 81 nM hCK2a-4,5,6-Br3Bt Kd =
83 nM hCK2a-TBBt Kd = 45 nM
ITC The binding events determined as
dissociation constant hCK2a-5-BrBt Kd = 310
nM hCK2a-5,6-Br2Bt Kd = 1170 nM hCK2a-
4,5,6-Br3Bt Kd = 990 nM hCK2a-TBBt Kd = 350
nM
[62]
Characterization of
RAS Protein
inhibitor
Different mutants of KRAS gene and
small synthetic molecule (3144)
The binding events determined as dissociation
constant (KRASG12D)-3144 Kd = 9 mM
ITC The binding events determined as
dissociation constant (KRASG12D-GTP)-3144 Kd
= 17.8 mM
[63]
Characterization of
RNR inhibitors
R2 subunit of ribonucleotide
reductase (R2-RNR) and different
synthetic thiosemicarbazones
The binding events determined as dissociation
constant R2-H2L2 Kd = 2.7 mM R2-compound3
Kd = 3.3 mM
[64]
Membrane protein
production
Olfactory receptor (mOR103-15)
and heptanal
The binding events determined as EC50
(mOR103-15)-heptanal EC50 = 9 mM
[65]
Characterization of
antibody
aggregation
IgG1 antibody (bevacizumab) and
AMP
The binding events determined as dissociation
constant using twoMST systems MST labelFree
system Bevacizumab-AMP Kd = 9.59 mM MST
with labeling system Bevacizumab-AMP Kd =
22 mM
[66]
Structural
characterization of
glycoprotein
(Avidin)
Avidin (small tetrameric
glycoprotein) and
hydroxyazobenzene carboxylic acid
(HABA)
The binding events determined as dissociation
constant Avidin-HABA Kd = 4.12 mM
[67]
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and development, protein characterization and catalytic mecha-
nisms. For instance, Schubert et al. [71] characterized the role of
small nucleolar RNA (snoRNA) and chromatin associated protein
known as decondensation factor 31 (Df31) in maintaining accessi-
bility of higher-order structure of chromatin. MST was successfully
used to evaluate the binding affinity of Df31 toward RNA in the
presence of other nucleic acids competitors. Additionally, the affin-
ity of Df31 toward different histone molecules (major components
of chromatin) was investigated as well as of direct interaction
between Df31 and snoRNA species (Me28S-U2134b, Me28S-
G980) in order to prove the role of snoRNA and Df31 in chromatin
as high-order structure mediators. Df31 exhibited higher affinity
toward snoRNAs fragments in presence of random RNA fragments
(Fig. 5). Similarly, Zillner et al. [72] investigated the binding event
for specific peptides known as (AT-hook) of Tip5 protein (major
regulatory subunit in nucleolar remodeling complex) with ribo-
zyme DNA (rDNA) in order to identify the regulatory function of
Tip5 protein in regulation of higher-order rDNA chromatin struc-
ture. MST results revealed weak affinity in comparison to control
(HMGA1). Furthermore, Gaffarogullari et al. [73] used MST to
investigate the interaction of small-molecule substrate to RNA
enzyme known as Diels-Alderase ribozyme (DAse) while, previous
approaches using FCS technique failed to quantitate the binding
event due to interference with small-molecule labeling procedures
for maleimide dienophiles substrate. MST approach used via two
experimental sets: the first analyzed the binding interactions
between DAse and diene substrates that was successfully investi-
gated by FCS to access the suitability of MST, which exhibited good
agreement with FCS measurements. The second experimental set
investigated the interaction between DAse and maleimide dieno-
phile substrates. MST but not FCS was reliably used in the determi-
nation of the dissociation constant for DAse-maleimide dienophile
substrates. MST of nucleic interactions are summarized in Table 3.
3.3. MST nucleic acids aptamer interactions
Among middle molecular weight biomolecules, aptamer gained
significant attention in recent years due to high-binding affinity
Table 2 (continued)
Analytical application Interacting molecules MST binding parameters Comparative techniques Ref.
Characterization of
Serum protein
binding domain
Bovine serum albumin (BSA) and
FITC dye in presence of competitive
drugs
The binding events determined as dissociation
constant (Warfarin-BSA)-FITC Kd = 1.24 mM
(Ibuprofen-BSA)-FITC not determined
FT The binding events determined as
association constant (Warfarin-BSA)-FITC Ka =
2.09  106 M (Ibuprofen-BSA)-FITC Ka = 0.93
 106 M
[68]
Characterization of
fibrillar protein
aggregates
a-synuclein fibrils (a-Syn) and Tau
fibrils against small molecules
The binding events determined as dissociation
constant -a-synuclein - small molecules Kd
range of 285–3100 nM -Tau - small molecules
Kd range of 2–123 nM
[69]
Fig. 5. A) represent two different labeled fragments (G980 part 1 and G980 part 2) of synthesized snoRNA species Me28S-G980. B) binding curve of Df31-Me28S-G980 in
presence of nonspecific RNAmolecules. C) competitive binding curve of Df31-G980-2 in presence of nonspecific molecules RNA. D) competitive binding curve of Df31-Me28S-
U2134b in presence of nonspecific RNA molecules. (Adapted with permission from Ref. [71]).
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and specificity. Aptamers consist of single- strand oligonucleotide
or peptide sequences which are selected and generated in vitro
by a selection process known as the systemic evolution of ligands
by exponential enrichment (SELEX). Today, aptamers are widely
used either as diagnostic or therapeutic agents [74–76]. In the ear-
lier evaluation of MST, aptamer binding studies were carried out
with different targeted molecules such as proteins and small mole-
cules. Baaske et al. used MST technique to quantify the buffer
dependence of aptamer binding [77]. Two approaches were per-
formed for aptamers interaction with macro/micro molecule part-
ners. The first approach was designed to study aptamer–protein
interaction where thrombin (37 kDa) was selected as a targeted
protein. Aptamer-protein interactions were carried out in pure buf-
fer system and in 10% and 50% human serum. The binding was
quantified as dissociation constant Kd = 30 nM in a pure buffer sys-
tem, which agrees with reported method while, in 10% and 50%
human serum the binding was fitted with Hill equation whereas
EC50 = 670 nM and 720 nM, respectively. The second approach
was carried out to investigate aptamer-small molecules interac-
tions: AMP and ATP were selected as targeted molecules to bind
with specific aptamer. The binding was quantified by Hill equation
as EC50 for AMP = 87 mM and ATP = 60 mM, which agreed with
reported values. In this context, Entzian et al. [38] applied another
approach to investigate aptamer-small molecule interaction where
ATP, AMP, ADP, SAM, dATP, Adenine, CTP and GTP were selected as
a targeted small molecules. The binding affinity fitted well with
Hill equation as EC50 in range of 28–68 mM except for CTP and
GTP that didn’t exhibit affinity to the aptamer. In contrast, apta-
mers were exploited as a bio-probe for such targeted molecules
[78–80]. Schax et al. [78] in another application to MST of aptamer
interaction, used specific aptamer as a probe for ochratoxin A con-
taminants in beer, coffee, juice, and wine. The method was success-
ful in determining ochratoxins A residuals in all selected samples
and the determined Kd values were in low micromolar concentra-
tions. Furthermore, Skouridou et al. [79] used specific aptamer (T5)
as a probe for testosterone (anabolic steroid) interactions. The
specific aptamer (T5) exhibited higher affinity to testosterone
among other candidates using MST pic instrument. The dissocia-
tion constant determined with MST Kd = 5.7 nM was in agreement
with Kd values that obtained from apta-PCR affinity assay (Kd = 4
nM). Recently, Zhu et al. [80] used MST to evaluate specifically
designed aptamer for cholic acid binding, exploited in developing
new biosensors for cholic acid detections used as aptamer-gold
nanoprobe. MST for aptamer interactions are summarized in
Table 3.
3.4. MST of miscellaneous applications
In this section, several applications of MST are discussed, such as
liposomal interactions, enzyme-metal ions interaction, and MST in
metal ions chelation, which are significant interactions and directly
involved in biological systems. MST of liposomal interactions were
studied by Bogaart et al. [81]. In this study, MST was used to quan-
tify the binding of phosphatidylinositol 4,5-Bisphosphate (PIP2) and
Ca2+ to synaptotagmin-1. Thus, the characterization of this binding
event is crucial to understanding the releasing mechanism of neu-
rotransmitters. MST proved that PIP2 binding to C2B domain of
synaptotagmin-1 to increase the sensitivity of synaptotagmin-1
toward Ca2+. Moreover, MST was used to investigate protein–metal
ions binding events due to high sensitivity to tiny conformational
changes of targeted macromolecules that lead to significant
changes in thermophoretic properties. Wienken et al. proved the
binding affinity to Ca2+ receptor calmodulin (CaM) with Ca2+ and
Mg2+. MST quantitated the dissociation constant for CaM-Ca2+ (Kd
= 2.8 mM) while no binding events was detected for Mg2+ [28]. Sim-
ilarly, Pang et al. [82] used MST to investigate the interaction
between oxalate oxidase (OxOx) and selected metal ions (Ca2+,
Fe3+). MST was used to investigate binding affinity between OxOx
and metal ions in different pH systems. Next, inhibitory effect of
metal ions for OxOx was evaluated using circular dichromism.
Table 3
MST of nucleic acids and nucleic acid aptamers interactions.
Analytical
application
Interacting molecules MST binding parameters Comparative techniques Ref.
MST of nucleic acids interactions
Characterization of
high order
structure of
Chromatin
Decondensation factor 31 (Df31) protein
and single or double strand RNA, histone
molecules and small nucleolar RNA
(snoRNA)
The binding events determined as Kd Df31 -
nonspecific RNA determined as Kd = 24 mM Df31-
histone H3 Kd = 1.5 mM Df31- histone H4 Kd = 12 mM
Df31 – snoRNA species Kd range of 7–14.5 mM
[71]
Characterization of
chromatin
regulatory
functions
AT-hook peptides and rDNA The binding events determined as EC50 where, EC50 of
different AT-hook peptide bound to rDNA in range of
1.4–7.9 mM
[72]
Ribozyme catalysis
mechanism
Diels-Alderase ribozyme (DAse) and
small molecules anthracene and
maleimide dienophiles
MST binding events determined as Kd (DAse)-9-DAP
Kd = 32 mM (DAse)-9-AB Kd = 1764 mM (DAse)-1-AB Kd
= 215 mM
FCS FCS binding events
determined as Kd (DAse)-9-DAP
Kd = 12 mM (DAse)-9-AB Kd = 1210
mM (DAse)-1-AB Kd = 300 mM
[73]
MST of nucleic acid aptamers interactions
Characterization of
aptamer
interaction to
small molecules
ATP aptamer and ATP, AMP, ADP, SAM,
dATP, Adenine, CTP and GTP
The binding events of ATP determined as EC50 and
compared to reported methods -Aptamer-ATP EC50 =
34.4 mM – other ligands EC50 in range of 28–68 mM
ATP-aptamer interactions
compared to Centrifugal filter Kd =
6 mM Isocratic elution Kd = 13 mM
[38]
Characterization of
aptamer binding
properties in
different media
Aptamer against thrombin, ATP and AMP The binding events was determined as Kd for Aptamer-
thrombin interactions where, Kd = 30 nM The binding
events was determined as EC50 for Aptamer-ATP/AMP
interactions. Aptamer-ATP EC50 = 60 mM Aptamer-
AMP EC50 = 87 mM
[77]
Ochratoxin A
probing
Aptamer 1.12.2 and ochratoxin A (OTA)
in different mixture
The binding events was determined as Kd Aptamer-
OTA in different mixture Kd in range of 2.60–4.81 mM
[78]
Steroid testosterones
probing
Aptamer and Testosterone 5 (T5)
candidate
The binding events of Aptamper-T5 was determined as
Kd = 5.7 nM
Apta PCR affinity assay (APAA)
Aptamer – T5 Kd = 4.0 nM
[79]
Cholic acid probing
(diagnostic
development)
Aptamer and cholic acid (CA) The binding event was determined as dissociation
constant Aptamer-CA Kd = 12.6 mM
[80]
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The binding affinity of OxOx toward Fe3+ was pH dependent
whereas interaction was very weak at pH 3.5 (Kd = 2.2 mM) and,
with increasing pH to 6.0, the interaction dramatically increased
(Kd = 0.49 mM) while Ca2+ didn’t exhibit any binding. Recently,
Asmari et al. [83] investigated the binding of iron-chelator deferi-
prone (CP20) to different essential metal ions. MST was used to
screen the affinity of CP20 towards Fe3+, Cu2+, Zn3+, Co2+, Ni2+,
Mn2+, Mg2+ and Ca2+. In this approach, under the constant MST con-
ditions the affinity of divalent metal ions to CP20 was varied where
Cu2+ and Zn2+ has a higher affinity to bind with CP20 than other
divalent metal ions (Fig. 6), which agrees with previous reports.
Mg2+ and Ca2+ did not show any binding affinity to CP20, which
are the most abundant metal ions in human body. MST data were
successfully fitted with Hill equations and EC50 was successfully
estimated. The system cooperativity was observed.
4. Conclusion
This review describes and summarizes recent studies of MST
techniques with biomolecular interactions. MST was successfully
used to analyse a wide range of molecules since the factors that
affect molecular thermophoresis do not depend solely on a change
of molecular size, which is difficult to detect in some cases but so
are any changes hydration shell or charges. The technical and
experimental approaches, as well as a comprehensive review of
theoretical background, are discussed in detail. Indeed, several
methodological challenges in other competitive techniques were
overcome in the MST system such as immobilization procedures,
high sample volumes, long time measurements, and simple han-
dling. We discussed in detail several applications of binding studies
using MST for protein-protein interactions, protein-small mole-
cules interaction, nucleic acids interactions, aptamer interaction
and non-categorized interaction studies, which revealed wide
application of the technique in the characterization of biomolecu-
lar interaction.
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